Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population

Area of Science:

• Endocrinology
• Metabolic Diseases
• Public Health

Background:

• Type-2 diabetes mellitus (T2DM) prevalence has surged in China, creating the world's largest T2DM population.
• T2DM pathogenesis involves insulin resistance and beta-cell dysfunction, with declining beta-cell function and mass being primary drivers of progression.

Purpose of the Study:

• To characterize beta-cell dysfunction in Chinese T2DM patients during disease progression.
• To compare beta-cell dysfunction in Chinese patients with other ethnicities.
• To identify risk factors, current treatments, and their impact on beta-cell function for improved T2DM therapy.

Main Methods:

• Literature review of studies on beta-cell function and T2DM progression in the Chinese population.
• Comparative analysis of ethnic differences in T2DM and beta-cell dysfunction.
• Synthesis of risk factors and therapeutic strategies impacting beta-cell function.

Main Results:

• Decreased beta-cell function and mass are predominant factors in T2DM progression.
• Significant ethnic variations exist in T2DM characteristics and beta-cell dysfunction.
• Risk factors and current treatments differentially affect beta-cell function in Chinese T2DM patients.

Conclusions:

• Characterizing beta-cell dysfunction in Chinese T2DM patients is essential due to ethnic-specific differences.
• Further research into risk factors and therapies impacting beta-cell function is needed for optimized T2DM management in China.